Venezuela Pharmaceuticals and Healthcare Report Q3 2014

  • July 2014
  • -
  • Business Monitor International
  • -
  • 128 pages

Includes 3 FREE quarterly updates

BMI View: Price controls, high inflation, currency devaluation, import and foreign currency controls, as well as other structurally distorting policies in Venezuela will continue to plague the country's pharmaceutical market until the end of President Maduro's first term.

Headline Expenditure Projections
- Pharmaceuticals: VEB59.85bn (USD9.85bn) in 2013 to VEB88.73bn (USD10.09bn) in 2014; +48.2% in local currency terms and 2.4% in US dollar terms. Forecast revised upwards from Q214 due to higher inflation forecast.
- Healthcare: VEB108.28bn (USD17.82bn) in 2013 to VEB154.91bn (USD17.61bn) in 2014; +43.1% in local currency terms and -1.2% in US dollar terms. Forecast down due to new historical data.

Table Of Contents

Venezuela Pharmaceuticals and Healthcare Report Q3 2014
BMI Industry View 7
SWOT .. 8
Political 10
Economic . 11
Business Environment 12
Industry Forecast .. 13
Pharmaceutical Market Forecast . 13
Table: Pharmaceutical Sales, Historical Data And Forecasts (Venezuela 2010-2018) 14
Healthcare Market Forecast . 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2010-2018) . . 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2010-2018) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2010-2018) . . 17
Prescription Market Forecast .. 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Venezuela 2010-2018) . . 18
Patented Drug Market Forecast .. 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Venezuela 2010-2018) 20
Generic Drug Market Forecast 21
Table: Generics Drug Market Indicators, Historical Data And Forecasts (Venezuela 2010-2018) 22
OTC Medicine Market Forecast .. 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Venezuela 2010-2018) . . 24
Pharmaceutical Trade Forecast .. 25
Table: Pharmaceutical Trade Data And Forecasts (Venezuela 2012-2018) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Venezuela 2012-2018) . . 28
Other Healthcare Data .. 29
Key Risks To BMI's Forecast Scenario 30
Macroeconomic Forecasts .. 32
Economic Analysis . 32
Table: Venezuela - Economic Activity 37
Industry Risk Reward Ratings 38
Americas Risk/Reward Ratings . 38
Venezuela Risk/Reward Ratings 44
Rewards . 44
Risks 45
Market Overview 46
Industry Trends And Developments .. 47
Epidemiology 47
Healthcare Sector Developments 50
Hospital Sector . 54
Private Healthcare Sector 61
Supply Chain . 65
Research And Development . 67
Regulatory Development .. 68
Regulatory Regime . 68
Intellectual Property . 69
Regulatory Developments 73
Pharmaceutical Registration .. 73
Advertising 75
Biologics And Biosimilars 75
Counterfeit Drugs 75
International Collaboration 76
Trade Agreements 77
Pricing Regime . 78
Reimbursement Regime 81
Competitive Landscape . 82
Pharmaceutical Sector . 82
Foreign Industry .. 83
Domestic Industry 85
Pharmaceutical Distribution .. 87
Production . 89
Company Developments .. 90
Company Profile . 93
Grupo Farma .. 93
Elmor 96
Strides Latina (Sumifarma) 99
Calox International . 101
Pfizer . 103
Sanofi . 107
GlaxoSmithKline . 109
Boehringer Ingelheim .. 112
Novartis . 114
Merck and Co .. 116
Demographic Forecast 118
Table: Venezuela's Population By Age Group, 1990-2020 ('000) . 119
Table: Venezuela's Population By Age Group, 1990-2020 (% of total) . 120
Table: Venezuela's Key Population Ratios, 1990-2020 . . 121
Table: Venezuela's Rural And Urban Population, 1990-2020 . 121
Glossary 122
Methodology .. 124
Pharmaceutical Expenditure Forecast Model .. 124
Healthcare Expenditure Forecast Model 124
Notes On Methodology .. 125
Risk/Reward Ratings Methodology . 126
Ratings Overview .. 127
Table: Pharmaceutical Risk/Reward Ratings Indicators . 127
Indicator Weightings . 128

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • February 2015
  • by Global Data

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 Summary Alzheimer’s Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, ...

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

  • $ 6 650
  • Industry report
  • May 2015
  • by BCC Research

This BCC Research study provides an in-depth analysis and forecast of selected areas of the global healthcare acquired infections (HAI) market. The report offers forecasts by treatment segment and type ...

Working Capital Management in the North American and European Pharmaceutical Industry : Optimization is the Key to Working Capital Efficiency

Working Capital Management in the North American and European Pharmaceutical Industry : Optimization is the Key to Working Capital Efficiency

  • $ 6 000
  • Industry report
  • April 2015
  • by Frost & Sullivan

Executive Summary Need for Effective Working Capital Management •Decreasing profitability •Fizzling innovation model •Access to new markets •Price premium pressure Key Trends •The analysis of ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.